Endonovo Therapeutics Pink Sheet Forecast - Naive Prediction
| ENDV Stock | USD 0.0007 0.0001 12.50% |
The Naive Prediction forecasted value of Endonovo Therapeutics on the next trading day is expected to be 0.0007 with a mean absolute deviation of 0.000066 and the sum of the absolute errors of 0. Endonovo Pink Sheet Forecast is based on your current time horizon.
Endonovo |
Endonovo Therapeutics Naive Prediction Price Forecast For the 3rd of December
Given 90 days horizon, the Naive Prediction forecasted value of Endonovo Therapeutics on the next trading day is expected to be 0.0007 with a mean absolute deviation of 0.000066, mean absolute percentage error of 0.00000001, and the sum of the absolute errors of 0.Please note that although there have been many attempts to predict Endonovo Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Endonovo Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Endonovo Therapeutics Pink Sheet Forecast Pattern
| Backtest Endonovo Therapeutics | Endonovo Therapeutics Price Prediction | Buy or Sell Advice |
Endonovo Therapeutics Forecasted Value
In the context of forecasting Endonovo Therapeutics' Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Endonovo Therapeutics' downside and upside margins for the forecasting period are 0.000007 and 9.87, respectively. We have considered Endonovo Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Endonovo Therapeutics pink sheet data series using in forecasting. Note that when a statistical model is used to represent Endonovo Therapeutics pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 99.384 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 1.0E-4 |
| MAPE | Mean absolute percentage error | 0.0644 |
| SAE | Sum of the absolute errors | 0.004 |
Predictive Modules for Endonovo Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Endonovo Therapeutics. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Endonovo Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Other Forecasting Options for Endonovo Therapeutics
For every potential investor in Endonovo, whether a beginner or expert, Endonovo Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Endonovo Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Endonovo. Basic forecasting techniques help filter out the noise by identifying Endonovo Therapeutics' price trends.View Endonovo Therapeutics Related Equities
| Risk & Return | Correlation |
Endonovo Therapeutics Technical and Predictive Analytics
The pink sheet market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Endonovo Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Endonovo Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Endonovo Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Endonovo Therapeutics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Endonovo Therapeutics shares will generate the highest return on investment. By undertsting and applying Endonovo Therapeutics pink sheet market strength indicators, traders can identify Endonovo Therapeutics entry and exit signals to maximize returns.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.88 | |||
| Day Median Price | 7.0E-4 | |||
| Day Typical Price | 7.0E-4 | |||
| Price Action Indicator | (0.00005) | |||
| Period Momentum Indicator | (0.0001) |
Endonovo Therapeutics Risk Indicators
The analysis of Endonovo Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Endonovo Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting endonovo pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.86 | |||
| Standard Deviation | 9.9 | |||
| Variance | 97.99 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Endonovo Pink Sheet Analysis
When running Endonovo Therapeutics' price analysis, check to measure Endonovo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Endonovo Therapeutics is operating at the current time. Most of Endonovo Therapeutics' value examination focuses on studying past and present price action to predict the probability of Endonovo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Endonovo Therapeutics' price. Additionally, you may evaluate how the addition of Endonovo Therapeutics to your portfolios can decrease your overall portfolio volatility.